(Q46087825)

19 December 2017

title

Metabotropic glutamate receptor II in the brains of Parkinsonian patients (English)

1 reference

19 December 2017

1 reference

3

1 reference

PubMed ID

19287314

19 December 2017

5

Oleh Hornykiewicz

1 reference

19 December 2017

author name string

Pershia Samadi

1

1 reference

19 December 2017

Alex Rajput

2

1 reference

19 December 2017

Laurent Grégoire

4

1 reference

19 December 2017

Ali H Rajput

6

1 reference

19 December 2017

Thèrèse Di Paolo

7

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

Journal of Neuropathology & Experimental Neurology

published in

1 reference

19 December 2017

volume

68

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

374-382

1 reference

19 December 2017

The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Levodopa and the progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Electrophysiology of dopamine in normal and denervated striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Metabotropic glutamate receptors in the basal ganglia motor circuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Metabotropic glutamate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Localization of metabotropic glutamate receptor type 2 in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

mGluRs: a target for pharmacotherapy in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Clinical-pathological study of levodopa complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

The roles of the caudate nucleus in human classification learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Cooperation between mglu receptors: a depressing mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Translating A2A antagonist KW6002 from animal models to parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0B013E31819CABE4

10.1097/NEN.0B013E31819CABE4

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19287314

1 reference

19 December 2017